Jonathan Wachtel
Child & Adolescent Psychiatry · White Plains, NYNPI 1144752668
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 413 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 413 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$1K
- Otsuka America Pharmaceutical, Inc.$993
- AbbVie$816
- Corium, LLC$649
- Lundbeck LLC$601
- Takeda Pharmaceuticals U.S.A., Inc.$580
- plus $3K from 15 others
What the payments were for
- Food & beverage$7,408100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 80 | $1,146 |
| Otsuka America Pharmaceutical, Inc. | 58 | $993 |
| AbbVie | 43 | $816 |
| Corium, LLC | 33 | $649 |
| Lundbeck LLC | 34 | $601 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $580 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $573 |
| Supernus Pharmaceuticals, Inc. | 15 | $419 |
| Almatica Pharma LLC | 20 | $369 |
| Neos Therapeutics, LP | 19 | $332 |
| Vertical Pharmaceuticals, LLC | 10 | $199 |
| Ironshore Pharmaceuticals Inc. | 9 | $188 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| Idorsia Pharmaceuticals US Inc | 5 | $99 |
| Collegium Pharmaceutical, Inc. | 4 | $79 |
| Vanda Pharmaceuticals Inc. | 4 | $75 |
| Neurocrine Biosciences, Inc. | 3 | $60 |
| Alkermes, Inc. | 2 | $46 |
| Noven Therapeutics, LLC | 2 | $34 |
| Neuronetics, Inc. | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$160
How this compares
$7,408 in reported general payments places this provider in the 95th percentile of 317 child & adolescent psychiatry providers in New York.
See all child & adolescent psychiatry providers in New York →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexmethylphenidate Hcl | 11 | $598 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in White Plains
- Parinda ParikhWhite Plains$185K
- Sunil SaxenaWhite Plains$6K
- Matthew LorberNew York$398K
- Mitchell CabisudoNew Windsor$346K
- Jeffrey NewcornNew York$165K
- John MarinoCanandaigua$70K
- Iliyan IvanovNew York$38K
- Melvin OatisNew York$35K
- Vijay PampanaMiddletown$19K
- Marc ReitmanHuntington$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.